#USA #Inari Medical #Portage #Artix Thrombectomy #Stryker Medical

Inari Medical Launches Artix Thrombectomy System

In a significant advancement for medical technology, Inari Medical, now part of Stryker, has revealed the Artix™ Thrombectomy System. This innovative device was designed specifically to tackle the complexities associated with arterial thrombus cases. The system combines both aspiration and mechanical thrombectomy methods, offering physicians greater procedural control and adaptability throughout treatment.

Addressing a Critical Need

Arterial blood clots, especially in the legs, represent a serious medical emergency that requires timely and effective intervention. Traditional methods of treating arterial thromboembolism often fall short, leading to complications such as ineffective clot retrieval, excessive blood loss, and the necessity for more invasive procedures like open surgery. With the launch of the Artix system, Inari Medical aims to transform the standard of care for these challenging cases.

Dr. Jonathan Bowman, Chief of Vascular at Norwalk Hospital, performed the first commercial procedure using the Artix system. His enthusiasm about the product is palpable. He stated, “The Artix Thrombectomy System marks a significant advancement in peripheral arterial thromboembolism treatment. With Artix, I finally have a solution that effectively addresses a wide range of clots while enabling me to maintain vessel access and retain control throughout the entire case.”

Key Features of Artix

The Artix system brings several innovative features that set it apart from existing solutions:

1. Dual Functionality: The Artix provides both mechanical thrombectomy and aspiration in one cohesive toolkit, capable of managing both acute and chronic clots during a single procedure.
2. Design and Flexibility: It features an 8 Fr. low-profile sheath that is kink-resistant and available in 65cm and 90cm lengths, which enhances treatment options and allows for more complex interventions.
3. Enhanced Retrieval Mechanism: The unique over-the-wire mechanical element is engineered to effectively collect and extract clots, streamlining the treatment process.
4. Risk Mitigation: A covered nitinol mesh funnel is designed to provide temporary flow restriction during procedures, lessening the risk of clot migration, a critical concern in related vascular procedures.

Tom Tu, MD, Chief Medical Officer at Inari Medical, emphasized the urgent need for improved solutions for chronic thrombi. He noted, “There is a real clinical need to address chronic thrombi and decrease the risk of clot migration. Artix will raise the bar of effective arterial thrombectomy.”

The Future of Arterial Thrombectomy

Inari Medical’s Artix system is positioned to play a pivotal role in changing how medical professionals approach arterial thrombus cases. By harnessing the company’s expertise honed from its successful venous thrombectomy devices, Artix seeks to redefine treatment expectations for patients suffering from arterial clot complications.

For healthcare providers and patients alike, the promise of improved outcomes with the Artix system could be a game-changer. As the company moves forward, the focus remains on delivering effective, reliable solutions that contribute positively to the healthcare landscape.

For further information on the Artix system, visit Inari Medical’s official website.

This launch comes following Stryker's acquisition of Inari Medical on February 19, 2025, allowing greater reach and resource sharing to advance medical technologies further. Together, they aim to enhance patient care and outcomes across various medical needs.

• ---